METHOD FOR DETERMINING DOSE protamine sulphate in cardiosurgical patients

摘要

method u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 dose u043fu0440u043eu0442u0430u043cu0438u043du0430 sulfate u043au0430u0440u0434u0438u043eu0445u0438u0440u0443u0440u0433u0438u0447u0435u0441u043au0438u0445 got sick, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 because patients in venous blood u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 hematocrit and plasma - with holding a residual u0430u043du0442u043d - ha activity.then the concentration of free heparin given the volume of circulating plasma and the extent of u0433u0435u043cu043eu0434u0438u043bu044eu0446u0438u0438; after which u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 total excess heparin in the circulating plasma and its content are more u043fu0440u043eu0442u0430u043cu0438u043du0430 sulfate administrated dose formula;fs = {[]} and u043eu0446u043fu0431 / in / 85;where fs is the dose u043fu0440u043eu0442u0430u043cu0438u043du0430 sulfate, mg;;a u043au043eu043du0446u0435u043du0442u0440u0430u0446u0438u00a0 free heparin, me / ml;;b - hematocrit at the time of u0438u0441u0441u043bu0435u0434u043eu0432u0430u043du0438u00a0, g / l;;the baseline hematocrit, g / l;;u043eu0446u043f circulating plasma volume, ml